DOI:
10.1055/s-00000034
Klinische Pädiatrie
LinksClose Window
References
Kishnani PS, Goldenberg PC, DeArmey SL. et al.
Crossreactive immunologic material status affects treatment outcomes in Pompe disease infants.
Mol Genet Metab 2010;
99: 26-33
Access:
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.